Bita Taghizadeh

Bita Taghizadeh

Auto-generated profile, based on publicly available information

Bita Taghizadeh

Institute of Biochemistry & Biophysics, University of Tehran, Tehran, Iran

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2014 in Drug Delivery
Verified
Journal Article
Closed access
BTBita Taghizadeh
Bita Taghizadeh
STShahrouz Taranejoo
Shahrouz Taranejoo
SMSeyed Ali Monemian
Seyed Ali Monemian
ZMZoha Salehi Moghaddam
Zoha Salehi Moghaddam
KDKarim Daliri
Karim Daliri
ZDZaynab Derakhshani
Zaynab Derakhshani
Although several anticancer drugs have been introduced as chemotherapeutic agents, the effective treatment of cancer remains a challenge. Major limitations in the application of anticancer drugs include their nonspecificity, wide biodistribution, short half-life, low concentration in tumor tissue and systemic toxicity. Drug delivery to the tumor site has become feasible in recent years, and recent advances in the development of new drug delivery systems for controlled drug release in tumor tissues with reduced side effects show great promise. In this field, the use of biodegradable polymers as drug carriers has attracted the most attention. However, drug release is still difficult to control even when a polymeric drug carrier is used. The design of pharmaceutical polymers that respond to external stimuli (known as stimuli-responsive polymers) such as temperature, pH, electric or magnetic field, enzymes, ultrasound waves, etc. appears to be a successful approach. In these systems, drug release is triggered by different stimuli. The purpose of this review is to summarize different types of polymeric drug carriers and stimuli, in addition to the combination use of stimuli in order to achieve a better controlled drug release, and it discusses their potential strengths and applications. A survey of the recent literature on various stimuli-responsive drug delivery systems is also provided and perspectives on possible future developments in controlled drug release at tumor site have been discussed.

7 September 2013 in Breast Cancer
Verified
Journal Article
Closed access
PDF file
BTBita Taghizadeh
Bita Taghizadeh
LGLaleh Ghavami
Laleh Ghavami
ANAlireza Nikoofar
Alireza Nikoofar
BGBahram Goliaei
Bahram Goliaei

1 December 2014 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
LGLaleh Ghavami
Laleh Ghavami
BGBahram Goliaei
Bahram Goliaei
BTBita Taghizadeh
Bita Taghizadeh
ANAlireza Nikoofar
Alireza Nikoofar

5 November 2025 in Chinese Herbal Medicines
Verified
Journal Article
Open access
AAAida Alizamir
Aida Alizamir
MKMasoud Khanaghaei
Masoud Khanaghaei
FMFarshad Mirzavi
Farshad Mirzavi
ANAli Nokhodchi
Ali Nokhodchi
LGLaleh Ghavami
Laleh Ghavami
BTBita Taghizadeh
Bita Taghizadeh